Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase II Trial of LMB-2, Fludarabine and Cyclophosphamide for Adult T-Cell Leukemia
NCT00924170Phase 2Completed
- Sponsor
- National Cancer Institute
- Start
- Oct 2008
- Primary completion
- Jan 2016
- Modality
- Immunotoxins
- Countries
- 1
01
Overview
A Phase 2 trial of LMB-2 in adult T-cell leukemia/lymphoma (ATLL), sponsored by National Cancer Institute. Started Oct 2008; status: completed.
02
Drugs
LMB-2
03
Conditions
adult T-cell leukemia/lymphoma (ATLL)
Beyond the preview
Go deeper on NCT00924170.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00924170.